Introduction
For decades, the population of Afghanistan has lived with armed con£ict, displacement and traumatisation. Several studies have reported high levels of symptoms such as depression and anxiety among the general Afghan population Panter-Brick et al., 2009; Scholte et al., 2004) . There has also been a recent dramatic increase in opiate use. The 2009 United Nations O⁄ce on Drugs and Crime (UNODC) Drug Survey estimates there are 230,000 opium users and 120,000 heroin users, nationwide. This is a rise of 53% and 140%, respectively, compared to 2005 (UNODC, 2009). The same report indicates an annual prevalence of regular opiate use of 2.7% in the adult population. This increase is considered to be a consequence of socioeconomic shortcomings, an ample drug supply and an in£ux of returning refugees who initiated opiate use while displaced (Strathdee et al., 2006; Todd et al., 2009; UNODC, 2009 ). Traditionally, opium was eaten or smoked in Afghanistan. However, while in 2003 there was an estimated minimum of 470 injection drug users (IDUs) in Kabul (UNODC, 2003) , by 2007 this had risen to 1,250 IDUs (The World Bank, 2008) . Rising rates of injection use has been ascribed to returnees adopting it in neighbouring nations, and raises the fear of epidemics of blood-borne infections like HIV, and hepatitis B (HBV) and C (HCV) (Saif-ur-Rehman et al., 2007; Todd et al., 2007; UNODC,2003) . Of the 523 opiate users tested by the French nongovernmental organisation (NGO) Me¤ decins du Monde (MDM), in their drop-in centre in Kabul, by 2011, 4%, 27% and 7% tested positive for HIV, HCV and HBV, respectively (MDM, unpublished data).
Mental health among opiate users in Kabul: a pilot study from the Me¤ decins du Monde Harm Reduction Programme, Intervention 2012, Volume 10, Number 2, Harm reduction approaches, like needle exchange programmes (NSP) and addiction treatment [particularly opioid maintenance therapy (OMT)], are e¡ective in reducing high risk behaviours, morbidity and mortality, as well as slowing the spread of HIV (World Health Organization, 2004) . By late 2010, there were 15 detoxi¢cation centres (approximately 200 beds), 15 community based treatment facilities, 17 harm reduction drop-in centres, and 10 voluntary counselling and testing centres in Afghanistan (personal communication of Dr. Samaruddin, Harm Reduction Consultant, National AIDS Control Programme). Treatment is usually limited to 21-day detoxi¢ca-tion with benzodiazepines, non-steroidal anti-in£ammatory drugs and sometimes clonidine, followed occasionally by in-or outpatient counselling (Todd et al., 2009; Todd, Sa¢ & Strathdee, 2005; UNODC, 2005) . Treatment possibilities do not meet demand, and long waiting lists for inpatient treatment, high costs and lack of transportation further limit access. In 2005, only an estimated 0.25% of Afghan drug users were undergoing addiction treatment (UNODC, 2005) . MDM has been operating a harm reduction programme in Kabul since 2006, targeting prevention, care and treatment of IDUs, as well as the establishment of a national training and resource centre on harm reductionand HIV. It actively involves IDUs in promoting distribution of information and knowledge of available interventions in the community. The programme incorporates treatment of somatic conditions, e.g. antiretroviral therapy, basic pharmacological and psychosocial mental health treatment, as well as social counselling. Furthermore, it includes the only OMT programme in Afghanistan, initiated in February 2010.
In western settings, opiate users show a high prevalence of psychiatric comorbidity particularly major depression, antisocial personality disorder, and anxiety disorders (Brooner et al., 1997; Kidorf et al., 2004) . Similarly, a study on opiate users in Iran found a prevalence of 7% for major depression, and 55% for opiate induced depression (Ahmadi et al., 2003) . Psychiatric comorbidity may be associated with the severity of substance use (Brooner et al., 1997) , compromised outcome of addiction treatment (Rounsaville et al.,1986) , and high risk behaviours like injecting, needle sharing, prostitution and unsafe sex (King et al., 2000) . HIV-and HCV-seroconversion appears to be related to psychiatric symptoms and trauma (Woody et al., 1997) . Drug treatments, which addressed psychiatric comorbidity in an integrated way, yielded superior results regarding psychological functioning and reduction of opiate use (Grella & Stein, 2006) . This study aimed to identify psychiatric comorbidity and patterns of development of opiate use in male Afghans treated at the MDM drop-in centre in Kabul. With high levels of psychiatric symptoms present in the general population, and many returning refugees among opiate users, the authors expected a high number of individuals with psychiatric comorbidity.
Methods

Setting and participants
The MDM drop-in centre had 738 registered users in 2009, o¡ering comprehensive health care and social services (Maguet & Majeed, 2010 
Instruments
Psychiatric interviews were conducted with assistance of an interpreter. This method allows collection of in-depth information about psychiatric symptoms, and structured questions can be combined with an interview driven approach. Validity can be further enhanced by means of a translator serving as cultural advisor, giving the correct context to the statements of the interviews. Symptoms regarded as pathological in other settings, may then be rated as a cultural phenomenon (i.e. a normal reaction to stressful living conditions), or indeed pathological. Interpreters were university students, employed by MDM as translators and cultural mediators. Interviews lasted 45^60 minutes and comprised standardised questions concerning sociodemographic data and opiate use, followed by a semi-structured assessment of psychopathological symptoms. Personal history, patterns of drug use and symptoms were further explored via in-depth interviews.
Data analysis
Diagnostic evaluation of psychopathological symptoms, according to the diagnostic criteria of the WHO International Classi¢-cation of Diseases, Revision 10 (ICD-10, World Health Organization, 1992) and screening of in-depth information for drug use patterns was performed independently by two di¡erent researchers (S.T. and M.V.). When, after the in-depth exploration, it still remained unclear if symptoms were part of a 'normal' reaction to highly stressful living conditions, the authors were generally cautious to rate these as pathological. Due to the small sample size, analyses were limited to descriptive statistics.
Results
Opiate use behaviour and patterns of opiate use development Table 1 summarises sociodemographic and opiate use characteristics of the sample. The average initiation age of regular opiate use was 22.8 years (13^35 years). Twentyeight participants started by smoking, one began with sni⁄ng, and one with injecting. Mean duration of opiate use, before switching to injection use, was 5.8 years (1 month^16 years). After detoxi¢cation treatment, one person returned to smoking opiates after having injected for six years. In 28 users, displacement preceded opiate use, one was born in Iran and took up opiate use there before migrating to Afghanistan, and one had never left the country. All of the 22 individuals who started opiate use abroad did so in Iran. Seven participants began using after their return to Afghanistan. Of 24 current or former IDUs, 20 started injection use in Afghanistan, and 13 took up opiate smoking while displaced and started injecting after their return to Afghanistan. While four participants began both smoking and injecting outside of Afghanistan, six did so after returning to Afghanistan. Table 2 summarises the data on psychiatric comorbidity. Of the 30 sampled, 28 described symptoms indicative of at least one co-occurring psychiatric disorder, 12 of two or more. Symptoms of a depressive episode were reported by 26 participants, with 10 ful¢lling ICD-10 criteria for the category Mental health among opiate users in Kabul: a pilot study from the Me¤ decins du Monde Harm Reduction Programme, Intervention 2012, Volume 10, Number 2, Page 146 -155 '' severe' ' (World Health Organization, 1992) . Six interviewees were diagnosed with either panic disorder (ICD-10, F41.0) or generalised anxiety disorder (ICD-10, F41.1). None ful¢lled criteria for bipolar disorder. The depressive symptoms mentioned most were depressed mood (n¼28), anhedonia (i.e. the inability to experience pleasure from previously enjoyable activities) (n¼26), loss of interest (n¼23) and energy (n¼21), guilt feelings (n¼20) and disturbed sleep (n¼20). Only four participants reported a pessimistic view of the future, and only 10 reported reduced self-esteem or self-con¢-dence.Twenty-three interviewees mentioned exposure to traumatic events in the past, with 18 meeting ICD-10 criteria of posttraumatic stress disorder (PTSD). Traumatic events were mainly related to imprisonment, torture or witnessing of the death of a relative or friend, either due to drug use, illness or war related events. Psychotic symptoms were present in 15 participants, but only three ful¢lled diagnostic criteria for schizophrenia. 
Psychiatric comorbidity
Discussion
This is the ¢rst study reporting on psychiatric comorbidity and development of opiate use in Afghan opiate users. Psychiatric comorbidity exceeded that of both the Afghan general population, and other opiate dependent populations, with 93% reporting symptoms of at least one mental disorder.
The prevalence of depressive disorders is in the upper range described for opiate dependent patients (Brooner et al., 1997; Kidorf et al., 2004) . It is also higher than in studies of the general Afghan population Scholte et al., 2004) , although those estimates were made with standardised instruments, the validity of which was questioned in this context (Bolton & Betancourt, 2004) . As with other mental disorders, symptoms have to be critically evaluated in light of the cultural context. For example, admitting thoughts of hopelessness or reduced self-esteem may not co-exist with the Afghan male's role model of the proud head of a family. Indeed, these were rarely reported. Similarly, hopelessness might be looked upon as an evil notion, particularly in combination with suicidal ideation. The Quran has been interpreted as forbidding suicide (Nemati, 2007) and seven interviewees mentioned this. Although there may be a certain protective cultural element, these symptoms may have been underreported due to a desire to give socially acceptable answers. Of this sample, 77% reported exposure to traumatic events and 60% showed PTSD symptoms meeting clinical diagnosis of PTSD according to ICD-10. This indicates a higher prevalence than in both the general Afghan population and western opiate users, but conforms to that of other traumatised or displaced communities. A cross-sectional study, among Afghan refugees in Pakistan, attending a psychiatric clinic found a proportion of 80% (Naeem et al., 2005) . In displaced Iranian treatment seekers exposed to torture, PTSD was reported in 53% (Priebe & Esmaili, 1997 (Rodin & van Ommeren, 2009; Steel et al., 2009) . Di¡erences in clinical and research criteria for diagnosis of PTSD in ICD-10 further complicate comparisons (Johnson & Thompson, 2008) . Living conditions for IDUs in Kabul may further precipitate traumatic experiences and development of psychiatric comorbidity like PTSD and depression (Miller & Rasmussen, 2010) . For example, many opiate users are homeless and live under the Pol e Sokhta Bridge, where they face daily stressors like marginalisation, hygiene problems, infectious diseases, high mortality and frequent arrests by the police. Lack of social support has been described as a risk factor for sustained PTSD (Gorst-Unsworth & Goldenberg, 1998), and many participants reported loss of family contact (unpublished data). However, the clinical utility of the diagnosis of PTSD in Afghanistan has been questioned (Miller et al., 2009) . Some PTSD symptoms, such as irritability, sleeping problems or concentration de¢cits, may also be explained by opiate use itself, or the associated living conditions. Where this was clear, we did not rate these as pathological. Nevertheless, the symptoms are present on a phenomenological basis, cause psychological distress and possibly in£uence outcome of harm reduction measures. Compared to other drug using populations, the point prevalence of 10% for diagnosis of schizophrenia in our sample is substantial. None had received antipsychotics. In Afghanistan, treatment of this disorder has traditionally been performed by mullahs or healers, aiming to drive away the disease causing, evil spirit by a strict diet and the recitation of holy verses (van de Put, 2002) . Stigmatisation is even stronger than for other mental disorders. Additionally, opiate use may constitute an attempt at self-medication for psychotic symptoms, explaining the high prevalence. The substantial burden of psychiatric comorbidity found in this pilot study underlines the need for integrating mental health treatment in harm reduction and drug use programmes. Comorbidity has been linked to reduced success of these interventions, and to an increase of high risk behaviours (King et al., 2000; Rounsaville et al.,1986) . Addressing comorbid mental disorders would substantially improve treatment of Afghan opioid users. This should be done in integrated treatment centres, with expertise on both substance use and mental health disorders. Separation of both treatments, as is the prevailing practice in Afghanistan, is not merely illogical, but also jeopardises the outcome of interventions targeting the individual, as well as those combating the spread of HIV and HCV. Moreover, the small number of participants reporting previous treatment in this study illustrates the general need to expand treatment services. Treatment of mental disorders, which are widely regarded as being caused by evil spirits or witchcraft, is challenging in itself. Social marginalisation and the obstacles to gaining access to opiate users further complicate it. However, our experience shows that a variety of psychiatric interventions are possible within the context of harm reduction work in Afghanistan. For all conditions, psycho-education and the explanation and relativism of symptoms are crucial to improve compliance and adherence. This should occur on an individual basis, but can be supplemented e¡ectively through group interventions. We repeatedly o¡ered these in our tearoom and they were usually well accepted. Supportive therapy is particularly useful for depressive drug Mental health among opiate users in Kabul: a pilot study from the Me¤ decins du Monde Harm Reduction Programme, Intervention 2012, Volume 10, Number 2, Page 146 -155
As the study was cross-sectional, one cannot infer causality or temporal relations between opiate use and psychiatric comorbidity. Prospective studies among returning refugees could rectify this.
Conclusion
In this study, the authors found a very high comorbidity with depressive and anxiety disorders, PTSD and schizophrenia in a con- 
